Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.

Hutcheson KA, Warneke CL, Yao CMKL, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND; MD Anderson Head and Neck Cancer Symptom Working Group.

JAMA Otolaryngol Head Neck Surg. 2019 Sep 26. doi: 10.1001/jamaoto.2019.2725. [Epub ahead of print]

PMID:
31556933
2.

Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review.

Lu H, Lok AS, Warneke CL, Ahmed S, Torres HA, Martinez F, Suarez-Almazor ME, Foreman JT, Ferrajoli A, Hwang JP.

Lancet Haematol. 2018 Oct;5(10):e474-e478. doi: 10.1016/S2352-3026(18)30152-2.

3.

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases.

Parkes A, Warneke CL, Clifton K, Al-Awadhi A, Oke O, Pestana RC, Alhalabi O, Litton JK, Hortobagyi GN.

Oncologist. 2018 Nov;23(11):1282-1288. doi: 10.1634/theoncologist.2018-0085. Epub 2018 Aug 17.

4.

Characterization of bone only metastasis patients with respect to tumor subtypes.

Parkes A, Clifton K, Al-Awadhi A, Oke O, Warneke CL, Litton JK, Hortobagyi GN.

NPJ Breast Cancer. 2018 Jan 25;4:2. doi: 10.1038/s41523-018-0054-x. eCollection 2018.

5.

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.

Menegaz BA, Cuglievan B, Benson J, Camacho P, Lamhamedi-Cherradi SE, Leung CH, Warneke CL, Huh W, Subbiah V, Benjamin RS, Patel S, Daw N, Hayes-Jordan A, Ludwig JA.

Oncologist. 2018 Mar;23(3):360-366. doi: 10.1634/theoncologist.2017-0408. Epub 2017 Dec 6.

6.

Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors.

Hutcheson KA, Barrow MP, Warneke CL, Wang Y, Eapen G, Lai SY, Barringer DA, Plowman EK, Lewin JS.

Laryngoscope. 2018 Jul;128(7):1615-1621. doi: 10.1002/lary.26986. Epub 2017 Nov 8.

7.

Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades.

Goepfert RP, Lewin JS, Barrow MP, Warneke CL, Fuller CD, Lai SY, Weber RS, Hutcheson KA.

Dysphagia. 2018 Apr;33(2):185-191. doi: 10.1007/s00455-017-9843-x. Epub 2017 Aug 23.

8.

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.

Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A.

Ann Surg Oncol. 2017 Oct;24(10):2981-2988. doi: 10.1245/s10434-017-5952-x. Epub 2017 Aug 1.

PMID:
28766220
9.

Advance Directives, Hospitalization, and Survival Among Advanced Cancer Patients with Delirium Presenting to the Emergency Department: A Prospective Study.

Elsayem AF, Bruera E, Valentine A, Warneke CL, Wood GL, Yeung SJ, Page VD, Silvestre J, Brock PA, Todd KH.

Oncologist. 2017 Nov;22(11):1368-1373. doi: 10.1634/theoncologist.2017-0115. Epub 2017 Aug 1.

10.

Oncologic progress for the treatment of parathyroid carcinoma is needed.

Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND.

J Surg Oncol. 2016 Nov;114(6):708-713. doi: 10.1002/jso.24407. Epub 2016 Oct 18.

PMID:
27753088
11.

Treatment outcomes in pediatric melanoma-Are there benefits to specialized care?

Freemyer B, Hamilton E, Warneke CL, Ali AM, Herzog C, Hayes-Jordan A, Austin M.

J Pediatr Surg. 2016 Dec;51(12):2063-2067. doi: 10.1016/j.jpedsurg.2016.09.039. Epub 2016 Sep 17.

PMID:
27686483
12.

Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study.

Elsayem AF, Bruera E, Valentine AD, Warneke CL, Yeung SC, Page VD, Wood GL, Silvestre J, Holmes HM, Brock PA, Todd KH.

Cancer. 2016 Sep 15;122(18):2918-24. doi: 10.1002/cncr.30133. Epub 2016 Jul 25.

13.

Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer.

Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND.

Ann Surg Oncol. 2016 Sep;23(9):2889-97. doi: 10.1245/s10434-016-5248-6. Epub 2016 May 9.

PMID:
27160525
14.

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma.

Ho TH, Liu XD, Huang Y, Warneke CL, Johnson MM, Hoang A, Tamboli P, Wang F, Jonasch E.

BMC Cancer. 2015 Apr 18;15:304. doi: 10.1186/s12885-015-1302-1.

15.

Effect of concurrent metastatic disease on survival in children and adolescents undergoing lung resection for metastatic osteosarcoma.

Slade AD, Warneke CL, Hughes DP, Lally PA, Lally KP, Hayes-Jordan AA, Austin MT.

J Pediatr Surg. 2015 Jan;50(1):157-60; discussion 160. doi: 10.1016/j.jpedsurg.2014.10.038. Epub 2014 Oct 28.

PMID:
25598115
16.

Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy.

Morris LF, Lee S, Warneke CL, Abadin SS, Suliburk JW, Romero Arenas MA, Lee JE, Grubbs EG, Perrier ND.

Am J Surg. 2014 Nov;208(5):850-855. doi: 10.1016/j.amjsurg.2014.05.006. Epub 2014 Jul 11.

PMID:
25152254
17.

Number of excisions required to obtain clear surgical margins and prognostic value of AJCC T category for patients with eyelid melanoma.

Yin VT, Warneke CL, Merritt HA, Esmaeli B.

Br J Ophthalmol. 2014 Dec;98(12):1681-5. doi: 10.1136/bjophthalmol-2014-305140. Epub 2014 Jul 22.

PMID:
25053759
18.

Correlation of American Joint Committee on Cancer T category for eyelid carcinoma with outcomes in patients with periocular Merkel cell carcinoma.

Sniegowski MC, Warneke CL, Morrison WH, Nasser QJ, Frank SJ, Pfeiffer ML, El-Sawy T, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2014 Nov-Dec;30(6):480-5. doi: 10.1097/IOP.0000000000000153.

PMID:
24841735
19.

Impact of AJCC 'T' designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid.

Nasser QJ, Roth KG, Warneke CL, Yin VT, El Sawy T, Esmaeli B.

Br J Ophthalmol. 2014 Apr;98(4):498-501. doi: 10.1136/bjophthalmol-2013-304434. Epub 2014 Jan 15.

PMID:
24429279
20.

Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy.

Morris LF, Iupe IM, Edeiken-Monroe BS, Warneke CL, Hansen MO, Evans DB, Lee JE, Grubbs EG, Perrier ND.

Endocr Pract. 2013 Nov-Dec;19(6):1015-20. doi: 10.4158/EP12334.OR.

PMID:
24013973
21.

Complications in the surgical treatment of pediatric melanoma.

Palmer PE 3rd, Warneke CL, Hayes-Jordan AA, Herzog CE, Hughes DP, Lally KP, Austin MT.

J Pediatr Surg. 2013 Jun;48(6):1249-53. doi: 10.1016/j.jpedsurg.2013.03.018.

PMID:
23845614
22.

P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy.

Said R, Hong DS, Warneke CL, Lee JJ, Wheler JJ, Janku F, Naing A, Falchook GS, Fu S, Piha-Paul S, Tsimberidou AM, Kurzrock R.

Oncotarget. 2013 May;4(5):705-14.

23.

Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer.

Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN, Theriault RL.

Oncologist. 2013;18(4):369-76. doi: 10.1634/theoncologist.2012-0340. Epub 2013 Apr 10.

24.

Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience.

Rojas Y, Warneke CL, Dhamne CA, Tsao K, Nuchtern JG, Lally KP, Vasudevan SA, Hayes-Jordan AA, Cass DL, Herzog CE, Hicks MJ, Kim ES, Austin MT.

J Pediatr Surg. 2012 Dec;47(12):2199-204. doi: 10.1016/j.jpedsurg.2012.09.005.

PMID:
23217876
25.

Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.

Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND.

Surgery. 2012 Dec;152(6):1165-71. doi: 10.1016/j.surg.2012.08.056.

PMID:
23158186
26.

Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.

Chakravarti N, Peddareddigari VG, Warneke CL, Johnson MM, Overwijk WW, Hwu P, Prieto VG.

Am J Dermatopathol. 2013 Apr;35(2):184-90. doi: 10.1097/DAD.0b013e31825b2506.

PMID:
23147350
27.

The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer.

Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, Palla SL, Brewster A, Bruera E.

Oncologist. 2012;17(10):1240-5. doi: 10.1634/theoncologist.2012-0169. Epub 2012 Aug 17.

28.

Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.

Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG.

Ann Surg Oncol. 2013 Jan;20(1):53-9. doi: 10.1245/s10434-012-2589-7. Epub 2012 Aug 14.

29.

American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.

Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D.

Ophthalmology. 2012 May;119(5):1078-82. doi: 10.1016/j.ophtha.2011.11.006. Epub 2012 Feb 11.

30.

Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy?

Landry CS, Grubbs EG, Warneke CL, Ormond M, Chua C, Lee JE, Perrier ND.

Ann Surg Oncol. 2012 Apr;19(4):1269-74. doi: 10.1245/s10434-011-2075-7. Epub 2011 Nov 8.

PMID:
22065191
31.

Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.

Colombo C, Creighton CJ, Ghadimi MP, Bolshakov S, Warneke CL, Zhang Y, Lusby K, Zhu S, Lazar AJ, West RB, van de Rijn M, Lev D.

J Pathol. 2011 Dec;225(4):574-82. doi: 10.1002/path.2951. Epub 2011 Aug 8.

PMID:
21826666
32.

Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.

Chen JQ, Bao Y, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Katz RL, Sahin A, Bondy M, Murray JL, Radvanyi L.

Horm Cancer. 2011 Apr;2(2):132-43. doi: 10.1007/s12672-011-0067-5.

PMID:
21761336
33.

Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients.

Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F.

Ann Surg. 2011 Jul;254(1):119-24. doi: 10.1097/SLA.0b013e318217e97f.

34.

Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim KB, Hwu WJ, McIntyre S, Rohlfs M, Homsi J, Hwu P.

Melanoma Res. 2011 Feb;21(1):84-90. doi: 10.1097/CMR.0b013e328341445f. Review.

PMID:
21102360
35.

Clinical correlates of NRAS and BRAF mutations in primary human melanoma.

Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP, Wang LE, Prieto VG, Gershenwald JE, Wei Q, Grimm EA.

Clin Cancer Res. 2011 Jan 15;17(2):229-35. doi: 10.1158/1078-0432.CCR-10-2276. Epub 2010 Oct 25. Erratum in: Clin Cancer Res. 2011 Mar 15;17(6):1641.

36.

Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer.

Chen JQ, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Sahin A, Katz R, Bondy M, Hortobagyi G, Berinstein NL, Murray JL, Radvanyi L.

Horm Cancer. 2010 Feb;1(1):21-33. doi: 10.1007/s12672-010-0008-8. Epub 2010 Feb 13.

PMID:
21761348
37.

Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis.

Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NM.

Cancer. 2010 Jan 1;116(1):57-65. doi: 10.1002/cncr.24685.

38.

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D.

Am J Pathol. 2008 Nov;173(5):1518-27. doi: 10.2353/ajpath.2008.080475. Epub 2008 Oct 2.

39.

Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM.

J Clin Oncol. 2008 Sep 1;26(25):4072-7. doi: 10.1200/JCO.2007.14.4527.

40.

Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P.

Cancer Invest. 2008 Jul;26(6):624-33. doi: 10.1080/07357900802027073.

PMID:
18584354
41.

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P.

J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519.

PMID:
18569391
42.

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN.

J Bone Miner Res. 2008 Jun;23(6):826-36. doi: 10.1359/jbmr.080205.

43.

Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia.

Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ.

Am J Surg Pathol. 2008 Jun;32(6):936-42.

PMID:
18551751
44.

Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases.

Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, Granter SR, Seed P, Warneke CL, McKee PH, Calonje E.

Am J Surg Pathol. 2008 May;32(5):682-90. doi: 10.1097/PAS.0b013e3181590ba4.

PMID:
18347508
45.

Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.

Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, Warneke CL, Zhang PS, Hernandez V, Lopez-Terrada D, Pisters PW, Pollock RE, Lev D.

Clin Cancer Res. 2007 Dec 15;13(24):7314-21.

46.

Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis.

Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, Prieto VG.

Clin Cancer Res. 2007 Aug 15;13(16):4817-24.

47.

Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients.

Gupta S, Jain A, Warneke CL, Gupta A, Shannon VR, Morice RC, Onn A, Jimenez CA, Bashoura L, Giralt SA, Dickey BF, Eapen GA.

Bone Marrow Transplant. 2007 Jul;40(1):71-8. Epub 2007 May 7.

PMID:
17483846
48.

Texas hospitals' experience with the Texas Advance Directives Act.

Smith ML, Gremillion G, Slomka J, Warneke CL.

Crit Care Med. 2007 May;35(5):1271-6.

PMID:
17414082
49.

Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes.

Sarkiss MG, Yusuf SW, Warneke CL, Botz G, Lakkis N, Hirch-Ginsburg C, Champion JC, Swafford J, Shaw AD, Lenihan DJ, Durand JB.

Cancer. 2007 Feb 1;109(3):621-7.

50.

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG.

J Invest Dermatol. 2006 Jan;126(1):154-60.

Supplemental Content

Loading ...
Support Center